Mr.
Drone is a Managing Director and currently serves as Head
of
Houlihan Lokey’s Tax and Financial Reporting practice
as
well as
leader
of the firm’s
Pharmaceutical and Life Sciences (PLS)
business.
He
is
also a member of Houlihan Lokey’s Financial Advisory Services Leadership Team. Previous
to
this role,
Mr. Drone was
the global leader of PwC’s Deals business for the PLS sector for close to a
decade. He is based in the firm’s New York office.
Functionally,
Mr.
Drone is
a seasoned deal consultant with over 25 years of experience advising on
hundreds of transactions representing billions in transaction value and/or
capital. More
specifically,
he advises corporate and private equity clients on the structuring of complex M&A
transactions,
alliances, partnerships,
and
joint ventures,
as
well as minority investments, to
address financial reporting, corporate finance, and valuation issues.
In
addition, Mr.
Drone is
a leading advisor within the valuation community on valuation principles, methodologies,
and
critical assumptions employed in various business enterprise, intangible asset,
and
security valuation exercises across the spectrum of life science industries,
including pharmaceuticals, biotech, medical device, diagnostics, generics,
consumer, animal health, healthcare services, contract manufacturers,
and
contract research organizations. His clients range
from start-up biotech and medical device companies to the largest global life
science companies.
Mr.
Drone, who
is both a CPA
and CFA,
received a B.S. in Accounting from Bucknell
University and
an MBA in
Finance and Economics from the University of Chicago.